{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:13:37Z","timestamp":1781280817606,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900287"],"award-info":[{"award-number":["81900287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianshan Youth Foundation of Xinjiang","award":["2019Q066"],"award-info":[{"award-number":["2019Q066"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-022-01883-w","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T10:02:57Z","timestamp":1669716177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["ITF2357 induces cell cycle arrest and apoptosis of meningioma cells via the PI3K-Akt pathway"],"prefix":"10.1007","volume":"40","author":[{"given":"Lingying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Marhaba\u00b7Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongxin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6447-844X","authenticated-orcid":false,"given":"Zeyidan","family":"Jiapaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"key":"1883_CR1","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1097\/scs.0000000000003555","volume":"28","author":"DH Lee","year":"2017","unstructured":"Lee DH, Sim HS, Hwang JH, Kim KS, Lee SY. Extracranial meningioma presenting as an eyebrow mass. J Craniofac Surg. 2017;28:e305\u20137. https:\/\/doi.org\/10.1097\/scs.0000000000003555.","journal-title":"J Craniofac Surg"},{"key":"1883_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23:1231\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noab106.","journal-title":"Neuro Oncol"},{"key":"1883_CR3","doi-asserted-by":"publisher","first-page":"908745","DOI":"10.3389\/fsurg.2022.908745","volume":"9","author":"K Piper","year":"2022","unstructured":"Piper K, et al. Radiation of meningioma dural tail may not improve tumor control rates. Front Surg. 2022;9:908745. https:\/\/doi.org\/10.3389\/fsurg.2022.908745.","journal-title":"Front Surg"},{"key":"1883_CR4","doi-asserted-by":"publisher","DOI":"10.3171\/2020.7.Jns201042","author":"TP Gupte","year":"2020","unstructured":"Gupte TP, et al. Clinical and genomic factors associated with seizures in meningiomas. J Neurosurg. 2020. https:\/\/doi.org\/10.3171\/2020.7.Jns201042.","journal-title":"J Neurosurg"},{"key":"1883_CR5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/neuonc\/noz005","volume":"21","author":"IS Muskens","year":"2019","unstructured":"Muskens IS, et al. Body mass index, comorbidities, and hormonal factors in relation to meningioma in an ethnically diverse population: the Multiethnic Cohort. Neuro Oncol. 2019;21:498\u2013507. https:\/\/doi.org\/10.1093\/neuonc\/noz005.","journal-title":"Neuro Oncol"},{"key":"1883_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.851758","volume":"12","author":"B Patel","year":"2022","unstructured":"Patel B, et al. Identification and management of aggressive meningiomas. Front Oncol. 2022;12: 851758. https:\/\/doi.org\/10.3389\/fonc.2022.851758.","journal-title":"Front Oncol"},{"key":"1883_CR7","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1600-0404.1987.tb05474.x","volume":"75","author":"J Kunert-Radek","year":"1987","unstructured":"Kunert-Radek J, Stepien H, Radek A, Pawlikowski M. Somatostatin suppression of meningioma cell proliferation in vitro. Acta Neurol Scand. 1987;75:434\u20136. https:\/\/doi.org\/10.1111\/j.1600-0404.1987.tb05474.x.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"1883_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/biomedicines6030086","volume":"6","author":"F Nigim","year":"2018","unstructured":"Nigim F, Wakimoto H, Kasper EM, Ackermans L, Temel Y. Emerging medical treatments for meningioma in the molecular era. Biomedicines. 2018;6(3):86. https:\/\/doi.org\/10.3390\/biomedicines6030086.","journal-title":"Biomedicines"},{"key":"1883_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/532451","author":"B Murny\u00e1k","year":"2015","unstructured":"Murny\u00e1k B, Bogn\u00e1r L, Klekner \u00c1, Hortob\u00e1gyi T. Epigenetics of meningiomas. Biomed Res Int. 2015. https:\/\/doi.org\/10.1155\/2015\/532451.","journal-title":"Biomed Res Int"},{"key":"1883_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41579-019-0286-2","volume":"18","author":"MA S\u00e1nchez-Romero","year":"2020","unstructured":"S\u00e1nchez-Romero MA, Casades\u00fas J. The bacterial epigenome. Nat Rev Microbiol. 2020;18:7\u201320. https:\/\/doi.org\/10.1038\/s41579-019-0286-2.","journal-title":"Nat Rev Microbiol"},{"key":"1883_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.clineuro.2017.05.002","volume":"158","author":"V Galani","year":"2017","unstructured":"Galani V, et al. Genetic and epigenetic alterations in meningiomas. Clin Neurol Neurosurg. 2017;158:119\u201325. https:\/\/doi.org\/10.1016\/j.clineuro.2017.05.002.","journal-title":"Clin Neurol Neurosurg"},{"issue":"14","key":"1883_CR12","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.3390\/jcm10143150","volume":"10","author":"PD Tatman","year":"2021","unstructured":"Tatman PD, et al. High-throughput mechanistic screening of epigenetic compounds for the potential treatment of meningiomas. J Clin Med. 2021;10(14):3150. https:\/\/doi.org\/10.3390\/jcm10143150.","journal-title":"J Clin Med"},{"key":"1883_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00432-018-2800-8","volume":"145","author":"F Marampon","year":"2019","unstructured":"Marampon F, et al. Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma. J Cancer Res Clin Oncol. 2019;145:393\u2013409. https:\/\/doi.org\/10.1007\/s00432-018-2800-8.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1883_CR14","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1182\/blood.v98.9.2865","volume":"98","author":"RL Piekarz","year":"2001","unstructured":"Piekarz RL, et al. Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report. Blood. 2001;98:2865\u20138. https:\/\/doi.org\/10.1182\/blood.v98.9.2865.","journal-title":"Blood"},{"key":"1883_CR15","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2017.4177","author":"E Samukawa","year":"2017","unstructured":"Samukawa E, et al. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest. Int J Oncol. 2017. https:\/\/doi.org\/10.3892\/ijo.2017.4177.","journal-title":"Int J Oncol"},{"key":"1883_CR16","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3519","author":"Y Yang","year":"2018","unstructured":"Yang Y, et al. c-Myc regulates the CDK1\/cyclin B1 dependent-G2\/M cell cycle progression by histone H4 acetylation in Raji cells. Int J Mol Med. 2018. https:\/\/doi.org\/10.3892\/ijmm.2018.3519.","journal-title":"Int J Mol Med"},{"key":"1883_CR17","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3389\/fonc.2020.01491","volume":"10","author":"J Liu","year":"2020","unstructured":"Liu J, Xia C, Wang G. Multi-omics analysis in initiation and progression of Meningiomas: from pathogenesis to diagnosis. Front Oncol. 2020;10:1491. https:\/\/doi.org\/10.3389\/fonc.2020.01491.","journal-title":"Front Oncol"},{"key":"1883_CR18","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1158\/0008-5472.Can-12-1888","volume":"73","author":"SS Burns","year":"2013","unstructured":"Burns SS, et al. Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth. Cancer Res. 2013;73:792\u2013803. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-1888.","journal-title":"Cancer Res"},{"key":"1883_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00401-019-02008-w","volume":"138","author":"N Paramasivam","year":"2019","unstructured":"Paramasivam N, et al. Mutational patterns and regulatory networks in epigenetic subgroups of meningioma. Acta Neuropathol. 2019;138:295\u2013308. https:\/\/doi.org\/10.1007\/s00401-019-02008-w.","journal-title":"Acta Neuropathol"},{"key":"1883_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jhep.2004.10.020","volume":"42","author":"S Armeanu","year":"2005","unstructured":"Armeanu S, et al. Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357. J Hepatol. 2005;42:210\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2004.10.020.","journal-title":"J Hepatol"},{"key":"1883_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41389-018-0026-x","volume":"7","author":"M Di Martile","year":"2018","unstructured":"Di Martile M, et al. Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma. Oncogenesis. 2018;7:20. https:\/\/doi.org\/10.1038\/s41389-018-0026-x.","journal-title":"Oncogenesis"},{"key":"1883_CR22","doi-asserted-by":"publisher","first-page":"105647","DOI":"10.1016\/j.clineuro.2019.105647","volume":"190","author":"BJA Pereira","year":"2020","unstructured":"Pereira BJA, et al. Cyclin E1 expression and malignancy in meningiomas. Clin Neurol Neurosurg. 2020;190:105647. https:\/\/doi.org\/10.1016\/j.clineuro.2019.105647.","journal-title":"Clin Neurol Neurosurg"},{"key":"1883_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bioorg.2016.09.008","volume":"69","author":"B Mun","year":"2016","unstructured":"Mun B, Park YJ, Sung GH, Lee Y, Kim KH. Synthesis and antitumor activity of (-)-bassianolide in MDA-MB 231 breast cancer cells through cell cycle arrest. Bioorg Chem. 2016;69:64\u201370. https:\/\/doi.org\/10.1016\/j.bioorg.2016.09.008.","journal-title":"Bioorg Chem"},{"key":"1883_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/15384101.2021.1995684","volume":"21","author":"Q Liu","year":"2022","unstructured":"Liu Q, et al. Anti-tumor effect of ginkgetin on human hepatocellular carcinoma cell lines by inducing cell cycle arrest and promoting cell apoptosis. Cell Cycle. 2022;21:74\u201385. https:\/\/doi.org\/10.1080\/15384101.2021.1995684.","journal-title":"Cell Cycle"},{"key":"1883_CR25","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1007\/s11033-022-07117-6","volume":"49","author":"H Abdik","year":"2022","unstructured":"Abdik H. Antineoplastic effects of erufosine on small cell and non-small cell lung cancer cells through induction of apoptosis and cell cycle arrest. Mol Biol Rep. 2022;49:2963\u201371. https:\/\/doi.org\/10.1007\/s11033-022-07117-6.","journal-title":"Mol Biol Rep"},{"key":"1883_CR26","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1080\/15384101.2017.1383577","volume":"16","author":"SL Liu","year":"2017","unstructured":"Liu SL, et al. GSK3\u03b2-dependent cyclin D1 and cyclin E1 degradation is indispensable for NVP-BEZ235 induced G0\/G1 arrest in neuroblastoma cells. Cell Cycle. 2017;16:2386\u201395. https:\/\/doi.org\/10.1080\/15384101.2017.1383577.","journal-title":"Cell Cycle"},{"key":"1883_CR27","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.2147\/jir.S350109","volume":"15","author":"M Wang","year":"2022","unstructured":"Wang M, et al. Microglia-mediated neuroinflammation: a potential target for the treatment of cardiovascular diseases. J Inflamm Res. 2022;15:3083\u201394. https:\/\/doi.org\/10.2147\/jir.S350109.","journal-title":"J Inflamm Res"},{"key":"1883_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7457105","author":"C Meng","year":"2019","unstructured":"Meng C, Teng Y, Jiang X. Raddeanin A induces apoptosis and cycle arrest in human HCT116 cells through PI3K\/AKT pathway regulation in vitro and in vivo. Evid Based Complement Alternat Med. 2019. https:\/\/doi.org\/10.1155\/2019\/7457105.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1883_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2020.07.137","author":"E Amirani","year":"2020","unstructured":"Amirani E, Hallajzadeh J, Asemi Z, Mansournia MA, Yousefi B. Effects of chitosan and oligochitosans on the phosphatidylinositol 3-kinase-AKT pathway in cancer therapy. Int J Biol Macromol. 2020. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.07.137.","journal-title":"Int J Biol Macromol"},{"key":"1883_CR30","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.mcr-19-0748","author":"SA Miller","year":"2019","unstructured":"Miller SA, et al. Lysine-specific demethylase 1 mediates AKT activity and promotes epithelial-mesenchymal transition in PIK3CA mutant colorectal cancer. Mol Cancer Res. 2019. https:\/\/doi.org\/10.1158\/1541-7786.mcr-19-0748.","journal-title":"Mol Cancer Res"},{"key":"1883_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317712617","author":"Y Song","year":"2017","unstructured":"Song Y, et al. The Wnt\/\u03b2-catenin and PI3K\/Akt signaling pathways promote EMT in gastric cancer by epigenetic regulation via H3 lysine 27 acetylation. Tumor Biology. 2017. https:\/\/doi.org\/10.1177\/1010428317712617.","journal-title":"Tumor Biology"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-022-01883-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-022-01883-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-022-01883-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T03:33:27Z","timestamp":1673840007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-022-01883-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["1883"],"URL":"https:\/\/doi.org\/10.1007\/s12032-022-01883-w","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]},"assertion":[{"value":"19 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author reports no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"21"}}